Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.

Int J Chron Obstruct Pulmon Dis · 2018 · PMC5914546 · PMID 29719383

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In general, IC 50 and IC 30 values showed a trend to be lower in HS compared to COPD patients.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Inhibition of CXCL10 was numerically greater with AZD7624 compared to budesonide, but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.